Ballicules.com

Caffeine and Regadenoson: an Adenosine A2A receptor interaction

Caffeine blocks the adenosine A2A receptor, so Regadenoson cannot act there — the effect of Regadenoson is reduced or lost.

Regadenoson is an agonist at the adenosine A2A receptor: it binds and switches the receptor on. Caffeine is an antagonist at the same site and switches nothing on. With both present they compete for the same pocket, and whichever is there in greater effective concentration decides what the receptor does.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Regadenoson’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Caffeine versus Regadenoson over the Adenosine A2A receptor
Fight club: Caffeine versus Regadenoson — Adenosine A2A receptor

The two ballicules, with the Adenosine A2A receptor lit on each

Caffeine ballicule, with its Adenosine A2A receptor peg ringed
Caffeine (CAFCIT)
Adenosine A2A receptor antagonist
Regadenoson ballicule, with its Adenosine A2A receptor peg ringed
Regadenoson (LEXISCAN)
Adenosine A2A receptor agonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Caffeine mascot mnemonic cartoon
Caffeine
A dino sign (adenosine) antagonist
Regadenoson mascot mnemonic cartoon
Regadenoson
Lexi, Regal dino

Open it in the console